Linagliptin for elderly patients with type 2 diabetes

Lancet. 2014 Jan 25;383(9914):307. doi: 10.1016/S0140-6736(14)60103-3.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Dipeptidyl-Peptidase IV Inhibitors / therapeutic use*
  • Female
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Male
  • Purines / therapeutic use*
  • Quinazolines / therapeutic use*

Substances

  • Dipeptidyl-Peptidase IV Inhibitors
  • Hypoglycemic Agents
  • Purines
  • Quinazolines